Trastuzumab for the Treatment of Salivary Duct Carcinoma

OBJECTIVES. Salivary duct carcinoma (SDC) is a rare and aggressive malignancy with high mortality and poor response to treatment. A significant fraction of SDCs are HER2 positive. This retrospective review examines HER2 testing in SDC and the outcome of trastuzumab-based therapy in adjuvant and pall...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Limaye, Sewanti A., Posner, Marshall R., Krane, Jeffrey F., Fonfria, Maria, Lorch, Jochen H., Dillon, Deborah A., Shreenivas, Aditya V., Tishler, Roy B., Haddad, Robert I.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2013
Onderwerpen:
Head and Neck Cancers
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607526/
https://ncbi.nlm.nih.gov/pubmed/23429737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0369
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items